Can treatment of nocturia increase testosterone level in men with late onset hypogonadism?

Jong Wook Kim, Ji Yun Chae, Jin Wook Kim, Cheol Yong Yoon, Mi-Mi Oh, Hong Seok Park, Je-Jong Kim, Du Geon Moon

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective To assess the effect of desmopressin on serum testosterone level in men with nocturia and late onset hypogonadism. Methods We prospectively enrolled men with nocturia and symptoms of late onset hypogonadism. Desmopressin (0.1 mg) was administered once daily to patients for 12 weeks, and we then compared serum testosterone levels, electrolytes, frequency volume chart indices, and changes in the International Prostate Symptom Score (IPSS), International Index of Erectile Function, and Aging Male's Symptom scales before and after treatment. Patients with a history of cardiovascular disease or hyponatremia, those using hypnotics, and those who had primary hypogonadism or hypogonadotrophic hypogonadism were excluded from the study. Results Sixty-two men (mean age, 68.4 years) completed pre- and post-treatment questionnaires and underwent laboratory testing. At the end of the study, the testosterone levels in men with low testosterone levels (<3.5 ng/mL) increased after the 12-week desmopressin treatment (2.85 ± 0.58 to 3.97 ± 1.44 ng/mL; P =.001). Mean scores had decreased from 17.7 to 13.9 (IPSS), 3.8 to 3.2 (IPSS-Quality of Life), and 33.7 to 31.1 (Aging Male's Symptom). On the frequency volume chart, nocturnal urine volume, nocturnal polyuria index, actual number of nocturia events, nocturia index, and nocturnal bladder capacity index were significantly decreased. Conclusion Desmopressin improved nocturia and other urinary symptoms. Moreover, serum testosterone levels increased significantly in men with low testosterone levels after 12-week desmopressin treatment.

Original languageEnglish
Pages (from-to)837-842
Number of pages6
JournalUrology
Volume83
Issue number4
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Nocturia
Hypogonadism
Deamino Arginine Vasopressin
Testosterone
Prostate
Therapeutics
Serum
Polyuria
Hyponatremia
Hypnotics and Sedatives
Electrolytes
Urinary Bladder
Cardiovascular Diseases
Quality of Life
Urine

ASJC Scopus subject areas

  • Urology

Cite this

Can treatment of nocturia increase testosterone level in men with late onset hypogonadism? / Kim, Jong Wook; Chae, Ji Yun; Kim, Jin Wook; Yoon, Cheol Yong; Oh, Mi-Mi; Park, Hong Seok; Kim, Je-Jong; Moon, Du Geon.

In: Urology, Vol. 83, No. 4, 01.01.2014, p. 837-842.

Research output: Contribution to journalArticle

Kim, Jong Wook ; Chae, Ji Yun ; Kim, Jin Wook ; Yoon, Cheol Yong ; Oh, Mi-Mi ; Park, Hong Seok ; Kim, Je-Jong ; Moon, Du Geon. / Can treatment of nocturia increase testosterone level in men with late onset hypogonadism?. In: Urology. 2014 ; Vol. 83, No. 4. pp. 837-842.
@article{d1a30322c1914af2a87bf09c5b6e39c0,
title = "Can treatment of nocturia increase testosterone level in men with late onset hypogonadism?",
abstract = "Objective To assess the effect of desmopressin on serum testosterone level in men with nocturia and late onset hypogonadism. Methods We prospectively enrolled men with nocturia and symptoms of late onset hypogonadism. Desmopressin (0.1 mg) was administered once daily to patients for 12 weeks, and we then compared serum testosterone levels, electrolytes, frequency volume chart indices, and changes in the International Prostate Symptom Score (IPSS), International Index of Erectile Function, and Aging Male's Symptom scales before and after treatment. Patients with a history of cardiovascular disease or hyponatremia, those using hypnotics, and those who had primary hypogonadism or hypogonadotrophic hypogonadism were excluded from the study. Results Sixty-two men (mean age, 68.4 years) completed pre- and post-treatment questionnaires and underwent laboratory testing. At the end of the study, the testosterone levels in men with low testosterone levels (<3.5 ng/mL) increased after the 12-week desmopressin treatment (2.85 ± 0.58 to 3.97 ± 1.44 ng/mL; P =.001). Mean scores had decreased from 17.7 to 13.9 (IPSS), 3.8 to 3.2 (IPSS-Quality of Life), and 33.7 to 31.1 (Aging Male's Symptom). On the frequency volume chart, nocturnal urine volume, nocturnal polyuria index, actual number of nocturia events, nocturia index, and nocturnal bladder capacity index were significantly decreased. Conclusion Desmopressin improved nocturia and other urinary symptoms. Moreover, serum testosterone levels increased significantly in men with low testosterone levels after 12-week desmopressin treatment.",
author = "Kim, {Jong Wook} and Chae, {Ji Yun} and Kim, {Jin Wook} and Yoon, {Cheol Yong} and Mi-Mi Oh and Park, {Hong Seok} and Je-Jong Kim and Moon, {Du Geon}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.urology.2013.12.060",
language = "English",
volume = "83",
pages = "837--842",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Can treatment of nocturia increase testosterone level in men with late onset hypogonadism?

AU - Kim, Jong Wook

AU - Chae, Ji Yun

AU - Kim, Jin Wook

AU - Yoon, Cheol Yong

AU - Oh, Mi-Mi

AU - Park, Hong Seok

AU - Kim, Je-Jong

AU - Moon, Du Geon

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective To assess the effect of desmopressin on serum testosterone level in men with nocturia and late onset hypogonadism. Methods We prospectively enrolled men with nocturia and symptoms of late onset hypogonadism. Desmopressin (0.1 mg) was administered once daily to patients for 12 weeks, and we then compared serum testosterone levels, electrolytes, frequency volume chart indices, and changes in the International Prostate Symptom Score (IPSS), International Index of Erectile Function, and Aging Male's Symptom scales before and after treatment. Patients with a history of cardiovascular disease or hyponatremia, those using hypnotics, and those who had primary hypogonadism or hypogonadotrophic hypogonadism were excluded from the study. Results Sixty-two men (mean age, 68.4 years) completed pre- and post-treatment questionnaires and underwent laboratory testing. At the end of the study, the testosterone levels in men with low testosterone levels (<3.5 ng/mL) increased after the 12-week desmopressin treatment (2.85 ± 0.58 to 3.97 ± 1.44 ng/mL; P =.001). Mean scores had decreased from 17.7 to 13.9 (IPSS), 3.8 to 3.2 (IPSS-Quality of Life), and 33.7 to 31.1 (Aging Male's Symptom). On the frequency volume chart, nocturnal urine volume, nocturnal polyuria index, actual number of nocturia events, nocturia index, and nocturnal bladder capacity index were significantly decreased. Conclusion Desmopressin improved nocturia and other urinary symptoms. Moreover, serum testosterone levels increased significantly in men with low testosterone levels after 12-week desmopressin treatment.

AB - Objective To assess the effect of desmopressin on serum testosterone level in men with nocturia and late onset hypogonadism. Methods We prospectively enrolled men with nocturia and symptoms of late onset hypogonadism. Desmopressin (0.1 mg) was administered once daily to patients for 12 weeks, and we then compared serum testosterone levels, electrolytes, frequency volume chart indices, and changes in the International Prostate Symptom Score (IPSS), International Index of Erectile Function, and Aging Male's Symptom scales before and after treatment. Patients with a history of cardiovascular disease or hyponatremia, those using hypnotics, and those who had primary hypogonadism or hypogonadotrophic hypogonadism were excluded from the study. Results Sixty-two men (mean age, 68.4 years) completed pre- and post-treatment questionnaires and underwent laboratory testing. At the end of the study, the testosterone levels in men with low testosterone levels (<3.5 ng/mL) increased after the 12-week desmopressin treatment (2.85 ± 0.58 to 3.97 ± 1.44 ng/mL; P =.001). Mean scores had decreased from 17.7 to 13.9 (IPSS), 3.8 to 3.2 (IPSS-Quality of Life), and 33.7 to 31.1 (Aging Male's Symptom). On the frequency volume chart, nocturnal urine volume, nocturnal polyuria index, actual number of nocturia events, nocturia index, and nocturnal bladder capacity index were significantly decreased. Conclusion Desmopressin improved nocturia and other urinary symptoms. Moreover, serum testosterone levels increased significantly in men with low testosterone levels after 12-week desmopressin treatment.

UR - http://www.scopus.com/inward/record.url?scp=84897146424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897146424&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2013.12.060

DO - 10.1016/j.urology.2013.12.060

M3 - Article

C2 - 24680454

AN - SCOPUS:84897146424

VL - 83

SP - 837

EP - 842

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -